Ardent Health Partners (NYSE:ARDT) Receives “Overweight” Rating from Stephens

Ardent Health Partners (NYSE:ARDT)‘s stock had its “overweight” rating restated by stock analysts at Stephens in a research note issued to investors on Thursday,Benzinga reports. They currently have a $22.00 target price on the stock. Stephens’ price objective points to a potential upside of 42.86% from the stock’s previous close.

Other equities research analysts have also issued reports about the stock. Truist Financial decreased their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Bank of America lowered shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their target price for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Royal Bank of Canada reiterated an “outperform” rating and set a $23.00 price target on shares of Ardent Health Partners in a report on Thursday, November 14th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a report on Tuesday, December 17th. Finally, Leerink Partners boosted their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Ardent Health Partners has an average rating of “Buy” and a consensus target price of $21.36.

Ardent Health Partners Trading Up 9.9 %

Shares of ARDT stock opened at $15.40 on Thursday. Ardent Health Partners has a fifty-two week low of $13.63 and a fifty-two week high of $20.72. The stock’s fifty day moving average price is $15.29 and its two-hundred day moving average price is $16.87. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.31. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion. On average, equities analysts forecast that Ardent Health Partners will post 1.23 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Ardent Health Partners during the fourth quarter worth approximately $27,000. US Bancorp DE bought a new position in shares of Ardent Health Partners during the 4th quarter worth approximately $31,000. R Squared Ltd acquired a new stake in shares of Ardent Health Partners during the 4th quarter worth approximately $37,000. BNP Paribas Financial Markets bought a new stake in shares of Ardent Health Partners in the 3rd quarter valued at $42,000. Finally, New York State Common Retirement Fund bought a new stake in shares of Ardent Health Partners in the 4th quarter valued at $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.